Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.22%73.8214.4%$592.60m
AMGNAmgen Inc.
0.82%191.631.2%$555.78m
GILDGilead Sciences, Inc.
2.37%66.660.9%$548.11m
CELGCelgene Corporation
0.16%68.241.2%$494.74m
ILMNIllumina, Inc.
1.58%315.813.5%$344.91m
BIIBBiogen Inc.
-3.24%302.971.3%$344.21m
REGNRegeneron Pharmaceuticals, Inc.
1.50%381.132.6%$273.11m
AAgilent Technologies, Inc.
1.43%68.821.5%$217.61m
VRTXVertex Pharmaceuticals Incorporated
1.75%169.081.9%$217.12m
ALXNAlexion Pharmaceuticals, Inc.
0.34%109.902.0%$154.34m
INCYIncyte Corporation
2.07%66.162.5%$99.18m
EXASExact Sciences Corporation
0.67%67.5625.3%$94.33m
BLUEBluebird Bio, Inc.
-0.36%104.1914.4%$87.20m
SRPTSarepta Therapeutics, Inc.
0.88%116.7215.4%$85.20m
GBTGlobal Blood Therapeutics Inc
1.58%42.237.0%$82.13m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.